Clinical Trials Browser

Phase 2 × Lopinavir × Clear all

NCT04455958 2021-04-26

Lopinavir/Ritonavir for the Treatment of COVID-19 Positive Patients With Cancer and Immune Suppression in the Last Year

Phase 2 Withdrawn

Other hematologic neoplasm

Hematologic Neoplasms

NCT01095094 2013-06-10

Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma

Phase 2 Terminated

19 enrolled 9 charts

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Gliosarcoma